{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:59:02Z","timestamp":1776628742881,"version":"3.51.2"},"reference-count":35,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"DOI":"10.20945\/2359-3997000000543","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:11:35Z","timestamp":1670353895000},"source":"Crossref","is-referenced-by-count":2,"title":["Impact of hepatitis C virus eradication with direct-acting antivirals on glycidic metabolism"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-2957","authenticated-orcid":false,"given":"Juc\u00e9li M\u00e1rcia Hendges","family":"Sparvoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-0454","authenticated-orcid":false,"given":"Antonio Cardoso","family":"Sparvoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5994-735X","authenticated-orcid":false,"given":"Samuel de Carvalho","family":"Dumith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1227-5613","authenticated-orcid":false,"given":"Afonso Alexandre","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6379-0343","authenticated-orcid":false,"given":"Ana Luisa Machado de","family":"Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-2405","authenticated-orcid":false,"given":"La\u00eds","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8717-1520","authenticated-orcid":false,"given":"Vanusa","family":"Belarmino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-9876","authenticated-orcid":false,"given":"Vanusa Pousada da","family":"Hora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2821-2000","authenticated-orcid":false,"given":"Ana Maria Barral de","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-6417","authenticated-orcid":false,"given":"Carla Vitola","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"key":"key20221206140709_B1","volume-title":"Preval\u00eancia do anticorpo contra o v\u00edrus da hepatite \u201cC\u201d em pacientes com diabetes mellitus tipo 2 atendidos no hospital Universit\u00e1rio de Rio Grande","author":"Hendges Sparvoli","year":"2004","unstructured":"Hendges Sparvoli JM. Preval\u00eancia do anticorpo contra o v\u00edrus da hepatite \u201cC\u201d em pacientes com diabetes mellitus tipo 2 atendidos no hospital Universit\u00e1rio de Rio Grande [Disserta\u00e7\u00e3o de Mestrado]. Rio Grande: Universidade Federal do Rio Grande (FURG); 2004."},{"issue":"5","key":"key20221206140709_B2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4239\/wjd.v5.i5.586","article-title":"Hepatitis C virus infection and type 1 and type 2 diabetes mellitus","volume":"5","author":"Antonelli","year":"2014","unstructured":"Antonelli A. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes. 2014;5(5):586.","journal-title":"World J Diabetes"},{"issue":"5","key":"key20221206140709_B3","first-page":"293","article-title":"Metabolic manifestations and complications associated with chronic hepatitis C virus infection","volume":"12","author":"Wong","year":"2016","unstructured":"Wong RJ, Gish RG. Metabolic manifestations and complications associated with chronic hepatitis C virus infection. Gastroenterol Hepatol. 2016;12(5):293-9.","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"key20221206140709_B4","doi-asserted-by":"crossref","first-page":"188094","DOI":"10.1111\/jvh.13215","article-title":"Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance","volume":"27","author":"Russo","year":"2020","unstructured":"Russo FP, Zanetto A, Gambato M, Bortoluzzi I, Al Zoairy R, Franceschet E, et al. Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance. J Viral Hepat. 2020;27(2):188094.","journal-title":"J Viral Hepat"},{"issue":"7","key":"key20221206140709_B5","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1007\/s10620-019-05918-7","article-title":"Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis","volume":"65","author":"Chen","year":"2020","unstructured":"Chen Y, Ji H, Shao J, Jia Y, Bao Q, Zhu J, et al. Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis. Dig Dis Sci. 2020;65(7):1940-50.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"key20221206140709_B6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","unstructured":"Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study. J Infect Dis. 2012;206(4):469-77.","journal-title":"J Infect Dis"},{"issue":"11","key":"key20221206140709_B7","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2018-316234","article-title":"Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: A meta-analysis","volume":"67","author":"Cacoub","year":"2018","unstructured":"Cacoub P, Desbois AC, Comarmond C, Saadoun D. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: A meta-analysis. Gut. 2018;67(11):2025-34.","journal-title":"Gut"},{"issue":"2","key":"key20221206140709_B8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.gtc.2020.01.012","article-title":"Extrahepatic Manifestations of Chronic Viral C Hepatitis","volume":"49","author":"Petta","year":"2020","unstructured":"Petta S, Crax\u00ec A. Extrahepatic Manifestations of Chronic Viral C Hepatitis. Gastroenterol Clin North Am. 2020;49(2):347-60.","journal-title":"Gastroenterol Clin North Am"},{"issue":"11","key":"key20221206140709_B9","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.v20.i11.2888","article-title":"Interaction between hepatitis C virus and metabolic factors","volume":"20","author":"Kawaguchi","year":"2014","unstructured":"Kawaguchi Y, Mizuta T. Interaction between hepatitis C virus and metabolic factors. World J Gastroenterol. 2014;20(11):2888-901.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"key20221206140709_B10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11904-019-00466-1","article-title":"Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection","volume":"16","author":"Mohanty","year":"2019","unstructured":"Mohanty A, Salameh S, Butt AA. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection. Curr HIV\/AIDS Rep. 2019;16(5):389-94.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"key20221206140709_B11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cld.2017.03.004","article-title":"Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, Dyslipidemia","volume":"21","author":"Serfaty","year":"2017","unstructured":"Serfaty L. Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, Dyslipidemia. Clin Liver Dis. 2017;21(3):475-86.","journal-title":"Clin Liver Dis"},{"issue":"4","key":"key20221206140709_B12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/diacare.28.4.940","article-title":"Hepatitis C virus infection and human pancreatic \u03b2-cell dysfunction","volume":"28","author":"Masini","year":"2005","unstructured":"Masini M, Campani D, Boggi U, Menicagli M, Funel N, Pollera M, et al. Hepatitis C virus infection and human pancreatic \u03b2-cell dysfunction. Diabetes Care. 2005;28(4):940-1.","journal-title":"Diabetes Care"},{"issue":"5","key":"key20221206140709_B13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc11-1837","article-title":"Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action","volume":"35","author":"Brandman","year":"2012","unstructured":"Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012;35(5):1090-4.","journal-title":"Diabetes Care"},{"issue":"9","key":"key20221206140709_B14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc17-0485","article-title":"Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis c virus","volume":"40","author":"Hum","year":"2017","unstructured":"Hum J, Jou JH, Green PK, Berry K, Lundblad J, Hettinger BD, et al. Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis c virus. Diabetes Care. 2017;40(9):1173-80.","journal-title":"Diabetes Care"},{"issue":"2","key":"key20221206140709_B15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jmv.24954","article-title":"Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents","volume":"90","author":"Ciancio","year":"2018","unstructured":"Ciancio A, Bosio R, Bo S, Pellegrini M, Sacco M, Vogliotti E, et al. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents. J Med Virol. 2018;90(2):320-7.","journal-title":"J Med Virol"},{"key":"key20221206140709_B16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2020.01.010","article-title":"Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study","volume":"296","author":"Adinolfi","year":"2020","unstructured":"Adinolfi LE, Petta S, Fracanzani AL, Coppola C, Narciso V, Nevola R, et al. Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study. Atherosclerosis. 2020;296:40-7.","journal-title":"Atherosclerosis"},{"issue":"8","key":"key20221206140709_B17","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.numecd.2021.04.016","article-title":"Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes","volume":"31","author":"Sasso","year":"2021","unstructured":"Sasso FC, Pafundi PC, Caturano A, Galiero R, Vetrano E, Nevola R, et al. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes. Nutr Metab Cardiovasc Dis. 2021;31(8):2345-53.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"key20221206140709_B18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4172\/2155-6156.1000766","article-title":"The Effect of Hepatitis C Virus Eradication with New Direct Acting Antivirals on Glucose Homeostasis in Non-Diabetic Egyptian Patients","volume":"8","author":"Shehab-Eldin","year":"2017","unstructured":"Shehab-Eldin W, Nada A, Abdulla A, Eldeen SS. The Effect of Hepatitis C Virus Eradication with New Direct Acting Antivirals on Glucose Homeostasis in Non-Diabetic Egyptian Patients. J Diabetes Metab. 2017;8(10):8-11.","journal-title":"J Diabetes Metab"},{"key":"key20221206140709_B19","first-page":"1","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade","author":"Minist\u00e9rio da Sa\u00fade. Brasil","year":"2018","unstructured":"Minist\u00e9rio da Sa\u00fade. Brasil. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite C e Coinfec\u00e7\u00f5es. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de DST, Aids e Hepatites Virais. 2018. p. 1-72."},{"key":"key20221206140709_B20","first-page":"148","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade","author":"Minist\u00e9rio da Sa\u00fade. Brasil","year":"2019","unstructured":"Minist\u00e9rio da Sa\u00fade. Brasil. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite C e Coinfec\u00e7\u00f5es. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de DST, Aids e Hepatites Virais. 2019. p. 148-62."},{"key":"key20221206140709_B21","volume-title":"Diretrizes Brasileiras de Obesidade","author":"Associa\u00e7\u00e3o Brasileira para o Estudo da Obesidade e da S\u00edndrome Metab\u00f3lica (Abeso)","year":"2016","unstructured":"Associa\u00e7\u00e3o Brasileira para o Estudo da Obesidade e da S\u00edndrome Metab\u00f3lica (Abeso). Diretrizes Brasileiras de Obesidade . 4\u00aa ed. S\u00e3o Paulo, SP: Abeso; 2016.","edition":"4\u00aa ed."},{"issue":"2","key":"key20221206140709_B22","first-page":"178","article-title":"Diretrizes da sociedade Brasileira de Diabetes 2019-2020","volume":"8","author":"Sociedade Brasileira de Diabetes","year":"2019","unstructured":"Sociedade Brasileira de Diabetes. Diretrizes da sociedade Brasileira de Diabetes 2019-2020. Alamedas. 2019;8(2):178-80.","journal-title":"Alamedas"},{"issue":"7","key":"key20221206140709_B23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.","journal-title":"Diabetologia"},{"issue":"11","key":"key20221206140709_B24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kjms.2017.07.003","article-title":"The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents","volume":"33","author":"Huang","year":"2017","unstructured":"Huang JF, Huang CF, Yeh ML, Dai CY, Hsieh MH, Yang JF, et al. The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents. Kaohsiung J Med Sci. 2017;33(11):567-71.","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"key20221206140709_B25","first-page":"139","article-title":"Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: A cohort study","volume":"42","author":"Lanini","year":"2019","unstructured":"Lanini S, Bartolini B, Taibi C, Agresta A, Garbuglia AR, Montaldo C, et al. Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: A cohort study. New Microbiol. 2019;42(3):139-44.","journal-title":"New Microbiol"},{"issue":"12","key":"key20221206140709_B26","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/dom.14168","article-title":"Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study","volume":"22","author":"Adinolfi","year":"2020","unstructured":"Adinolfi LE, Petta S, Fracanzani AL, Nevola R, Coppola C, Narciso V, et al. Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study. Diabetes Obes Metab. 2020;22(12):2408-16.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"key20221206140709_B27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-019-2033-x","article-title":"Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study","volume":"17","author":"Rinaldi","year":"2019","unstructured":"Rinaldi L, Perrella A, Guarino M, Luca M, Piai G, Coppola N, et al. Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study. J Transl Med. 2019;17(1):292.","journal-title":"J Transl Med"},{"key":"key20221206140709_B28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","unstructured":"Asselah T, Marcellin P, Schinazi RF. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure? Liver Int. 2018;38:7-13.","journal-title":"Liver Int"},{"issue":"6","key":"key20221206140709_B29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/liv.14031","article-title":"Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C","volume":"39","author":"Li","year":"2019","unstructured":"Li J, Gordon SC, Rupp LB, Zhang T, Trudeau S, Holmberg SD, et al. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019;39(6):1027-32.","journal-title":"Liver Int"},{"issue":"9","key":"key20221206140709_B30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2019.1653184","article-title":"HCV treatment with direct acting antivirals improves the insulin sensitivity","volume":"17","author":"Alsebaey","year":"2019","unstructured":"Alsebaey A, Elhelbawy M, Abdel-Razek W, Hashim M, Elshenawy H, Waked I. HCV treatment with direct acting antivirals improves the insulin sensitivity. Expert Rev Anti Infect Ther. 2019;17(9):749-54.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"key20221206140709_B31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.15403\/jgld.2014.1121.273.daa","article-title":"Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C","volume":"27","author":"Weidner","year":"2018","unstructured":"Weidner P, Boettche D, Zimmerer T, Burgermeister E, Teufel A, Ebert MPA, et al. Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C. J Gastrointest Liver Dis. 2018;27(3):281-9.","journal-title":"J Gastrointest Liver Dis"},{"issue":"3","key":"key20221206140709_B32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1590\/s0004-2803.201800000-69","article-title":"Insulin Resistance Reduction After Sustained Virological Response with Direct Acting Antiviral: Not Every Population Improves","volume":"55","author":"Andrade","year":"2018","unstructured":"Andrade VG, Yamashiro FS, Oliveira CV, Moreira A, Winckler FC, Silva GF. Insulin Resistance Reduction After Sustained Virological Response with Direct Acting Antiviral: Not Every Population Improves. Arq Gastroenterol. 2018;55(3):274-8.","journal-title":"Arq Gastroenterol"},{"issue":"2","key":"key20221206140709_B33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/jcm9020563","article-title":"The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm","volume":"9","author":"Ribaldone","year":"2020","unstructured":"Ribaldone DG, Sacco M, Saracco GM. The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm. J Clin Med. 2020;9(2):563.","journal-title":"J Clin Med"},{"issue":"6","key":"key20221206140709_B34","article-title":"Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway","volume":"7","author":"Wang","year":"2012","unstructured":"Wang Q, Chen J, Wang Y, Han X, Chen X. Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway. PLoS One. 2012;7(6).","journal-title":"PLoS One"},{"issue":"4","key":"key20221206140709_B35","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.dsx.2019.07.032","article-title":"Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study)","volume":"13","author":"Boraie","year":"2019","unstructured":"Boraie MB, Elnaggar YA, Ahmed MO, Mahmoud AM. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study). Diabetes Metab Syndr Clin Res Rev. 2019;13(4):2641-6.","journal-title":"Diabetes Metab Syndr Clin Res Rev"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:12:09Z","timestamp":1670353929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/impact-of-hepatitis-c-virus-eradication-with-direct-acting-antivirals-on-glycidic-metabolism\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":35,"alternative-id":["10.20945\/2359-3997000000543"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000543","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]}}}